Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)‐mutant myelodysplastic syndromes subtype

Splicing factor 3B subunit 1 (SF3B1) mutations define a distinct myelodysplastic syndromes (MDS) patient group with a relatively favourable disease course and high response rates to luspatercept. Few data are available on bone marrow phenotype beyond ring sideroblasts in this subgroup of patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Duetz, Carolien, Westers, Theresia M., in ’t Hout, Florentien E. M., Cremers, Eline M. P., Alhan, Canan, Venniker‐Punt, Bianca, Visser‐Wisselaar, Heleen A., Chitu, Dana A., de Graaf, Aniek O., Smit, Linda, Jansen, Joop H., van de Loosdrecht, Arjan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Haematological malignancy ‐ Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252736/
https://www.ncbi.nlm.nih.gov/pubmed/33765355
http://dx.doi.org/10.1111/bjh.17414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252736/
https://www.ncbi.nlm.nih.gov/pubmed/33765355
http://dx.doi.org/10.1111/bjh.17414

Ejemplares similares